Pang Lee is based in Cooley’s Hong Kong office, his practice includes all areas of partnership, corporate and securities law with a concentration on the organization and investment in private funds and strategic investments in the tech industry. Pang has worked closely with members of the Hong Kong start-up community cultivating its emerging companies ecosystem, with a particular focus in healthcare and emerging technology companies. Pang regularly advises private fund managers and institutional investors on United States and Hong Kong regulatory and compliance matters.

Pang brings a global perspective in his work, having worked in New York, San Francisco, Hong Kong and Shanghai in over two decades of legal practice. Pang regularly speaks at regional industry conferences in China and Southeast Asia, including serving as a moderator at the AVCJ for well over a decade. He is a member of the firm’s pro bono committee.

He is ranked as a leading investment funds lawyer by Chambers Greater China, The Legal 500 Asia Pacific and IFLR1000 Asia Pacific.

Pang received his JD from the University of Pennsylvania Law School, and a BS from Massachusetts Institute of Technology. He is admitted to practice in New York and is a solicitor of Hong Kong.

Wei Zhou is the founding partner of CCV Capital. He has 11 years of successful entrepreneurship experience and 17 years of venture investment experience.

In 2007, Wei joined KPCB as a founding member of KPCB China. He then served as a Managing Partner of KPCB and led the technology investment team in Greater China. In 2017, Wei founded CCV Capital where he adheres to a visionary investment strategy. CCV Capital focuses on early-stage investments in artificial intelligence, robotics, autonomous driving, and green tech. He has maintained a unicorn rate of 35% in the first ten years of operations and continues to yield at least one unicorn each year.

The companies he invested in include: JD.com (NASDAQ:JD), VenusTech (002439), CreditEase (NYSE:YRD), Rong360 (NYSE:JT),ChineseAll(300364), Arrail Dental (HKSE:06639), Perfect Corp(NYSE:PERF), KJY water (301372), Ximalaya FM, Shukun Technology, MetaApp, Cowa Robot, Transsnet Financial, IceKredit, Quicktron, PPIO, U POWER Technology, etc.

Wei is a pioneer in China's fintech payment industry. Prior to CCV Capital, Wei had more than ten years of startup experience as founding member/founder before his Venture Capital career.

Wei has been named among China's Top 30 Venture Capitalists by Forbes China for five consecutive years and included in the Top 30 Most Influential Investors of the Year by Fortune, China's Top 10 Venture Capitalist by CV Awards, China's Top 10 Influential Investors by China Renaissance, and awarded Best Investor of the Year by Zero2IPO and China Venture.

Wei also serves as the treasurer of China Venture Capital and Private Equity Association ("CVCA"), the oldest and longest-running trade group representing the venture capital and private equity industry in Greater China.

Wei holds an M.B.A. degree from Wharton, University of Pennsylvania and a Bachelor's degree in Physics and Electronics Science from the University of Electronic Science and Technology of China. He is a long-term entrepreneurship mentor at Wharton Business School, Tsinghua PBC School of Finance, and Zero2IPO Sandhill College.

Sang Han is a Partner at Cento Ventures, overseeing investments and investor relations. He has over 20 years of professional experience in venture capital, incubation, and entrepreneurship spanning Korea, Southeast Asia, the Middle East, US, and Europe.
Before Cento, Sang was Managing Director of Temasek Lifesciences Accelerator, and prior to that, Senior Executive Director of Vertex Holdings, a venture capital investment entity wholly owned by Temasek Holdings. He started his venture capital career at Walden International, a US-based international venture capital firm which he joined after serving for a number of years in various software engineering roles at enterprise software startups in Korea.
Sang received a BSc in Computer Engineering from Seoul National University and an MBA from INSEAD.

Shin is Managing Partner at GLOBIS Capital Partners. Shin leads GLOBIS’s digital and healthcare investments. Ranked by Forbes Japan’s “Midas List Most Influential Venture Investor”1^st in 2018, 7^th in 2015, 10^th in 2020.

His track record includes: IPO iStyle, Aucfan, Kayac, Pixta, Mercari, and Lancers; M&A Shimauma Print System (acquired by CCC), nanapi (acquired by KDDI), and Coubic (acquired by hey). His current portfolio includes Timers, Mirrativ, FastDOCTOR, TANP, alu, Alp, Josys, AnotherBall, and newmo etc.

Prior to Globis, Shin led management consulting projects at Arthur D. Little. He received BA in Economics from University of Tokyo (graduation thesis with Honor), and MBA from Harvard Business School (Second Year Honor). Shin has 8+ years of overseas experience in England, Holland, and the US.

Mr. Park joined Legend Capital in 2005, and is now Managing Director of the firm in charge of cross border investment.

Mr. Park focuses on TMT and consumption investment, especially overseas investment centered on Korea, Japan and India. Mr. Park led investments of HYBE (KOSPI: 352820, the management agency of K-pop sensation BTS boy group), Any Color (Tokyo Stock Exchange: 5032), Zinus (KOSPI: 013890), Dexter Studios (KOSDAQ: 206560), Wipam (KOSDAQ: 332570), C-Channel (Tokyo Pro Market: 7691), LUNIT, L&P Cosmetics, Bespin Global, Healing Paper, PPB Studio and Vedantu.

Before joining Legend Capital in 2005, Mr. Park worked with Accenture Tokyo office.

Mr. Park holds a B.S. in Business Administration from Yonsei University in Korea, and MBAs from Keio University Graduate School of Business in Japan and Cheung Kong Graduate School of Business in China. He is a Kauffman Fellow.